Next Article in Journal
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
Next Article in Special Issue
Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer
Previous Article in Journal
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
Previous Article in Special Issue
Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer
 
 
Article

Article Versions Notes

Cancers 2023, 15(5), 1630; https://doi.org/10.3390/cancers15051630
Action Date Notes Link
article pdf uploaded. 6 March 2023 17:14 CET Version of Record https://www.mdpi.com/2072-6694/15/5/1630/pdf-vor
article supplementary file uploaded. 6 March 2023 17:14 CET - https://www.mdpi.com/2072-6694/15/5/1630#supplementary
article xml uploaded. 7 March 2023 09:03 CET Original file -
article pdf uploaded. 7 March 2023 09:03 CET Updated version of record https://www.mdpi.com/2072-6694/15/5/1630/pdf-vor
article html file updated 7 March 2023 09:05 CET Original file -
article xml uploaded. 8 March 2023 06:07 CET Update https://www.mdpi.com/2072-6694/15/5/1630/xml
article pdf uploaded. 8 March 2023 06:07 CET Updated version of record https://www.mdpi.com/2072-6694/15/5/1630/pdf
article html file updated 8 March 2023 06:08 CET Update -
article html file updated 20 March 2023 21:14 CET Update https://www.mdpi.com/2072-6694/15/5/1630/html
Back to TopTop